
Oxygenta Pharmaceutical Ltd is Rated Strong Sell
2026-05-31 10:10:18Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleWhen is the next results date for Oxygenta Pharmaceutical Ltd?
2026-05-20 23:19:01The next results date for Oxygenta Pharmaceutical Ltd is scheduled for 23 May 2026....
Read full news article
Oxygenta Pharmaceutical Ltd is Rated Strong Sell
2026-05-19 10:10:22Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Oxygenta Pharmaceutical Ltd is Rated Strong Sell
2026-05-08 10:10:22Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Oxygenta Pharmaceutical Ltd is Rated Strong Sell
2026-04-27 10:10:25Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Oxygenta Pharmaceutical Ltd is Rated Strong Sell
2026-04-16 10:10:16Oxygenta Pharmaceutical Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Oxygenta Pharmaceutical Ltd is Rated Strong Sell
2026-04-05 10:10:11Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleCompliances-Reg.24(A)-Annual Secretarial Compliance
26-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations 2018.
Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May 2026
23-May-2026 | Source : BSEOutcome of the Board meeting held on 23rd May 2026.
Audited Financial Results For The Quarter And Year Ended 31.03.2026.
23-May-2026 | Source : BSEAudited Financial Results for the Quarter and Year ended 31.03.2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available








